• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：肿瘤治疗电场（TTFields）在新诊断胶质母细胞瘤老年患者中的疗效和安全性：3期EF-14临床试验的亚组分析。

Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of methe Phase 3 EF-14 Clinical Trial.

作者信息

Ram Zvi, Kim Chae-Yong, Hottinger Andreas F, Idbaih Ahmed, Nicholas Garth, Zhu Jay-Jiguang

机构信息

Department of Neurosurgery, Tel Aviv Medical Center and Tel Aviv University School of Medicine, Tel Aviv, Israel.

Department of Neurosurgery, Seoul National University College of Medicine, Seoul, South Korea.

出版信息

Front Oncol. 2022 Apr 12;12:902929. doi: 10.3389/fonc.2022.902929. eCollection 2022.

DOI:10.3389/fonc.2022.902929
PMID:35494031
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9040518/
Abstract

[This corrects the article DOI: 10.3389/fonc.2021.671972.].

摘要

[本文更正了文章DOI：10.3389/fonc.2021.671972。]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7f8/9040518/065444515144/fonc-12-902929-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7f8/9040518/b42694a039be/fonc-12-902929-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7f8/9040518/065444515144/fonc-12-902929-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7f8/9040518/b42694a039be/fonc-12-902929-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7f8/9040518/065444515144/fonc-12-902929-g003.jpg

相似文献

1
Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of methe Phase 3 EF-14 Clinical Trial.勘误：肿瘤治疗电场（TTFields）在新诊断胶质母细胞瘤老年患者中的疗效和安全性：3期EF-14临床试验的亚组分析。
Front Oncol. 2022 Apr 12;12:902929. doi: 10.3389/fonc.2022.902929. eCollection 2022.
2
Erratum: Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial.勘误：更正：肿瘤治疗电场（TTFields）在新诊断胶质母细胞瘤老年患者中的疗效和安全性：3期EF-14临床试验的亚组分析。
Front Oncol. 2022 Jun 7;12:952053. doi: 10.3389/fonc.2022.952053. eCollection 2022.
3
Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial.肿瘤治疗电场（TTFields）用于新诊断胶质母细胞瘤老年患者的疗效和安全性：3期EF-14临床试验的亚组分析
Front Oncol. 2021 Sep 27;11:671972. doi: 10.3389/fonc.2021.671972. eCollection 2021.
4
Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study.替莫唑胺用于治疗新诊断的胶质母细胞瘤：一项成本效益研究。
J Med Econ. 2019 Oct;22(10):1006-1013. doi: 10.1080/13696998.2019.1614933. Epub 2019 May 20.
5
Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial.电场治疗对新诊断胶质母细胞瘤患者健康相关生活质量的影响：一项随机临床试验的二次分析。
JAMA Oncol. 2018 Apr 1;4(4):495-504. doi: 10.1001/jamaoncol.2017.5082.
6
Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a post hoc analysis of the EF-14 trial.肿瘤治疗电场联合化疗与单纯化疗用于胶质母细胞瘤首次复发的治疗：EF-14试验的事后分析
CNS Oncol. 2017 Jul;6(3):185-193. doi: 10.2217/cns-2016-0049. Epub 2017 Apr 12.
7
Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma.在新诊断的胶质母细胞瘤中，与单独使用替莫唑胺相比，替莫唑胺联合肿瘤治疗电场的随机 III 期试验 (EF-14) 中的健康相关生活质量、认知筛查和功能状态。
J Neurooncol. 2017 Dec;135(3):545-552. doi: 10.1007/s11060-017-2601-y. Epub 2017 Aug 28.
8
Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma.头皮保留放疗联合替莫唑胺同期肿瘤治疗野（SPARE）治疗新诊断胶质母细胞瘤患者的初步经验。
J Neurooncol. 2020 May;147(3):653-661. doi: 10.1007/s11060-020-03466-z. Epub 2020 Mar 23.
9
Correlation of Tumor Treating Fields Dosimetry to Survival Outcomes in Newly Diagnosed Glioblastoma: A Large-Scale Numerical Simulation-Based Analysis of Data from the Phase 3 EF-14 Randomized Trial.肿瘤治疗电场剂量学与新诊断胶质母细胞瘤生存结局的相关性：基于 3 期 EF-14 随机试验数据的大规模数值模拟分析。
Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1106-1113. doi: 10.1016/j.ijrobp.2019.04.008. Epub 2019 Apr 23.
10
Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma.胶质母细胞瘤患者中与肿瘤治疗电场相关的皮肤不良事件的预防与管理
Front Oncol. 2020 Jul 28;10:1045. doi: 10.3389/fonc.2020.01045. eCollection 2020.